Stroke is a major cause of disability worldwide, leaving 25 million people with severe impairments and unable to perform activities of daily living. SaisiR introduces a revolutionary therapy based on personalisation and neurotechnologies to bridge the gap between the brain and the upper limb. At its core, a brain-computer interface decodes brain signals to activate muscle stimulation and a robotic glove. Enhanced by neuromodulation, our system enables complex movements, fostering neuroplasticity and recovery. A Swissmedic-approved trial showed that 90% of patients improved, 60% significantly, and 40% became only moderately impaired, with lasting benefits and improvements in daily life. SaisiR aims to make this therapy accessible in clinics worldwide, transforming stroke rehabilitation.
Tech innovators of tomorrow face off at Startup Champions Seed Night 2025 (venturelab.swiss)
AIT India-Swiss Camp 2024/25: Sciencepreneurs discover the Swiss Innovation Ecosystem (venturelab.swiss)
Academia-Industry Training India 2024: Strengthening Swiss-Indian innovation ties (venturelab.swiss)
AIT India 2024 kick-off drives Swiss startups' Indian market exploration (venturelab.swiss)